Approval · Notice of Compliance 10105 · 2009
VIDEX EC: Notice of Compliance 10105
Issued March 19, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10105
- Date
- March 19, 2009
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIDEX EC | Not yet assigned | — |
Medicinal ingredients
- DIDANOSINE 125 MG per CAP
- DIDANOSINE 200 MG per CAP
- DIDANOSINE 250 MG per CAP
- DIDANOSINE 400 MG per CAP